Biomodifying the ‘natural’: from adaptive regulation to adaptive societal governance
Biomodifying technologies—such as gene editing, induced pluripotent stem cells and bioprinting— are being developed for a wide range of applications, from pest control to lab-grown meat. In medicine, regulators have responded to the challenge of evaluating modified ‘natural’ material as a therapeuti...
Main Authors: | Mourby, M, Bell, J, Morrison, M, Faulkner, A, Li, P, Bicudo, E, Webster, A, Kaye, J |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Oxford University Press
2022
|
Similar Items
-
Patent power in biomedical innovation: technology governance in biomodifying technologies
by: Bicudo, E, et al.
Published: (2022) -
Biomodifying technologies and experimental space: organisational and regulatory implications for the translation and valuation of health research
by: Morrison, M, et al.
Published: (2019) -
Biomodifying technologies Policy Briefing 1 “Making good targets for translational research”
by: Morrison, M, et al.
Published: (2020) -
Biomodifying technologies Policy Briefing 3 “Trends in customisation and personalisation of advanced therapies”
by: Morrison, M, et al.
Published: (2021) -
Biomodifying technologies Policy Briefing 2 “Accelerating innovation: speed and timing in translational research”
by: Morrison, M, et al.
Published: (2020)